FindTrial
Sign In

STUDYING THE POTENTIAL OF HOMEOPATHY AS AN ADJUVANT THERAPY TO STANDARD TREATMENT FOR NON-PROLIFERATIVE DIABETIC RETINOPATHY

EVALUATING THE EFFICACY OF INDIVIDUALISED TREATMENT IN HOMOEOPATHY AS AN ADJUVANT THERAPY TO STANDARD MEDICAL CARE IN THE MANAGEMENT OF NON-PROLIFERATIVE DIABETIC RETINOPATHY: A SINGLE BLIND, RANDOMIZED CONTROLLED TRIAL - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094985
Enrollment
30
Registered
2025-09-17
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E113- Type 2 diabetes mellitus with ophthalmic complications

Interventions

Intervention1: Individualized Homoeopathic treatment: along with standard medical care, Individualized Homoeopathy remedy prescribed according to classical homeopathic principles after comprehensive c

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinically confirmed Non proliferative diabetic retinopathy (mild to moderate severity) Currently receiving standard medical care for diabetes and Non proliferative diabetic retinopathy Willingness to participate with written consent

Exclusion criteria

Exclusion criteria: Proliferative diabetic retinopathy HbA1c more than 10.0 percent Hypertensive retinopathy Cases needing surgical intervention Recent (less than 6 months) ocular surgery Pregnancy or planned pregnancy during study period Current participation in other clinical trial Significant hepatic impairment having more than and including Class B child phug score Angle closure glaucoma Renal impairment with GFR less than 59 ml per min per 1.73m3

Design outcomes

Primary

MeasureTime frame
Change in Retinal microvasculature as measured by Retinal fundoscopy and assessed using ICDR scaleTimepoint: 6 months with monthly follow ups—

Secondary

MeasureTime frame
improvement in Vision-related quality of life (NEI-VFQ-25)Timepoint: 6 months with monthly follow ups—

Countries

India

Contacts

Public ContactDr Snehalkumar Harne

BHARATI VIDYAPEETH (Deemed to be University) HOMOEOPATHIC MEDICAL COLLEGE & HOMOEOPATHIC HOSPITAL

snehalkumar.harne@bharatividyapeeth.edu9890564928

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026